|
1
|
Cohen PA, Jhingran A, Oaknin A and Denny
L: Cervical cancer. Lancet. 393:169–182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sawaya GF, Smith-McCune K and Kuppermann
M: Cervical cancer screening: More choices in 2019. JAMA.
321:2018–2019. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Denny L, de Sanjose S, Mutebi M, Anderson
BO, Kim J, Jeronimo J, Herrero R, Yeates K, Ginsburg O and
Sankaranarayanan R: Interventions to close the divide for women
with breast and cervical cancer between low-income and
middle-income countries and high-income countries. Lancet.
389:861–870. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mohamad O, Sishc BJ, Saha J, Pompos A,
Rahimi A, Story MD, Davis AJ and Kim DWN: Carbon ion radiotherapy:
A review of clinical experiences and preclinical research, with an
emphasis on DNA Damage/Repair. Cancers (Basel). 9:piiE662017.
View Article : Google Scholar
|
|
5
|
Hagiwara Y, Oike T, Niimi A, Yamauchi M,
Sato H, Limsirichaikul S, Held KD, Nakano T and Shibata A:
Clustered DNA double-strand break formation and the repair pathway
following heavy-ion irradiation. J Radiat Res. 60:69–79. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hamada N, Imaoka T, Masunaga S, Ogata T,
Okayasu R, Takahashi A, Kato TA, Kobayashi Y, Ohnishi T, Ono K, et
al: Recent advances in the biology of heavy-ion cancer therapy. J
Radiat Res. 51:365–383. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Loeffler JS and Durante M: Charged
particle therapy-optimization, challenges and future directions.
Nat Rev Clin Oncol. 10:411–424. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Onishi M, Okonogi N, Oike T, Yoshimoto Y,
Sato H, Suzuki Y, Kamada T and Nakano T: High linear energy
transfer carbon-ion irradiation increases the release of the immune
mediator high mobility group box 1 from human cancer cells. J
Radiat Res. 59:541–546. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Matsumoto Y, Furusawa Y, Uzawa A, Hirayama
R, Koike S, Ando K, Tsuboi K and Sakurai H: Antimetastatic effects
of carbon-ion beams on malignant melanomas. Radiat Res.
190:412–423. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kamada T, Tsujii H, Blakely EA, Debus J,
De Neve W, Durante M, Jäkel O, Mayer R, Orecchia R, Pötter R, et
al: Carbon ion radiotherapy in Japan: An assessment of 20 years of
clinical experience. Lancet Oncol. 16:e93–e100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang P, Hu X, Liu B, Liu Z, Liu C, Cai J,
Gao F, Cui J, Li B and Yang Y: Effects of
12C6+ heavy ion radiation on dendritic cells
function. Med Sci Monit. 24:1457–1463. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sai S, Vares G, Kim EH, Karasawa K, Wang
B, Nenoi M, Horimoto Y and Hayashi M: Carbon ion beam combined with
cisplatin effectively disrupts triple negative breast cancer
stem-like cells in vitro. Mol Cancer. 14:1662015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oike T, Niimi A, Okonogi N, Murata K,
Matsumura A, Noda SE, Kobayashi D, Iwanaga M, Tsuchida K, Kanai T,
et al: Visualization of complex DNA double-strand breaks in a tumor
treated with carbon ion radiotherapy. Sci Rep. 6:222752016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ando K and Kase Y: Biological
characteristics of carbon-ion therapy. Int J Radiat Biol.
85:715–728. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lazar AA, Schulte R, Faddegon B, Blakely
EA and Roach M III: Clinical trials involving carbon-ion radiation
therapy and the path forward. Cancer. 124:4467–4476. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fossati P, Matsufuji N, Kamada T and
Karger CP: Radiobiological issues in prospective carbon ion therapy
trials. Med Phys. 45:e1096–e1110. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wakatsuki M, Kato S, Ohno T, Karasawa K,
Kiyohara H, Tamaki T, Ando K, Tsujii H, Nakano T, Kamada T, et al:
Clinical outcomes of carbon ion radiotherapy for locally advanced
adenocarcinoma of the uterine cervix in phase 1/2 clinical trial
(protocol 9704). Cancer. 120:1663–1669. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Danieau G, Morice S, Redini F, Verrecchia
F and Royer BB: New insights about the Wnt/β-catenin signaling
pathway in primary bone tumors and their microenvironment: A
promising target to develop therapeutic strategies? Int J Mol Sci.
20(pii): E37512019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hua F, Liu S, Zhu L, Ma N, Jiang S and
Yang J: Highly expressed long non-coding RNA NNT-AS1 promotes cell
proliferation and invasion through Wnt/β-catenin signaling pathway
in cervical cancer. Biomed Pharmacother. 92:1128–1134. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Loh KM, van Amerongen R and Nusse R:
Generating cellular diversity and spatial form: Wnt signaling and
the evolution of multicellular animals. Dev Cell. 38:643–655. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang B, Tian T, Kalland KH, Ke X and Qu Y:
Targeting Wnt/beta-catenin signaling for cancer immunotherapy.
Trends Pharmacol Sci. 39:648–658. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Oren O and Smith BD: Eliminating cancer
stem cells by targeting embryonic signaling pathways. Stem Cell
Rev. 13:17–23. 2017. View Article : Google Scholar
|
|
23
|
vallée A, Lecarpentier Y and Vallée JN:
Curcumin: A therapeutic strategy in cancers by inhibiting the
canonical WNT/β-catenin pathway. J Exp Clin Cancer Res. 38:3232019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bahrami A, Hasanzadeh M, ShahidSales S,
Yousefi Z, Kadkhodayan S, Farazestanian M, Joudi Mashhad M, Gharib
M, Mahdi Hassanian S and Avan A: Clinical significance and
prognosis value of wnt signaling pathway in cervical cancer. J Cell
Biochem. 118:3028–3033. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ramachandran I, Ganapathy V, Gillies E,
Fonseca I, Sureban SM, Houchen CW, Reis A and Queimado L: Wnt
inhibitory factor 1 suppresses cancer stemness and induces cellular
senescence. Cell Death Dis. 5:e12462014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ghosh N, Hossain U, Mandal A and Sil PC:
The Wnt signaling pathway: A potential therapeutic target against
cancer. Ann N Y Acad Sci. 1443:54–74. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma S, Deng X, Yang Y, Zhang Q, Zhou T and
Liu Z: The lncRNA LINC00675 regulates cell proliferation,
migration, and invasion by affecting Wnt/β-catenin signaling in
cervical cancer. Biomed Pharmacother. 108:1686–1693. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang G, Shen T, Yi X, Zhang Z, Tang C,
Wang L, Zhou Y and Zhou W: Crosstalk between long non-coding RNAs
and Wnt/beta-catenin signalling in cancer. J Cell Mol Med.
22:2062–2070. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lan K, Zhao Y, Fan Y, Ma B, Yang S, Liu Q,
Linghu H and Wang H: Sulfiredoxin may promote cervical cancer
metastasis via Wnt/β-catenin signaling pathway. Int J Mol Sci.
18(pii): E9172017.PubMed/NCBI
|
|
30
|
Kwan HT, Chan DW, Cai PC, Mak CS, Yung MM,
Leung TH, Wong OG, Cheung AN and Ngan HY: AMPK activators suppress
cervical cancer cell growth through inhibition of DVL3 mediated
Wnt/βand -catenin signaling activity. PLoS One. 8:e535972013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang J, Si J, Gan M, Yan J, Chen Y, Wang
F, Xie T, Wang Y and Zhang H: Inhibition of Wnt signalling pathway
by XAV939 enhances radiosensitivity in human cervical cancer HeLa
cells. Artif Cells Nanomed Biotechnol. 48:479–487. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen D, Zhang H, Jing C, He X, Yang B, Cai
J, Zhou Y, Song X, Li L and Hao X: Efficient synthesis of new
phenanthridine Wnt/β-catenin signaling pathway agonists. Eur J Med
Chem. 157:1491–1499. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen DZ, Yang BJ, He XL, Fan SR, Cai JY,
Jing CX, Zhang H, Zhang Y, Li L and Hao XJ: Design, synthesis and
structure-activity relationship optimization of phenanthridine
derivatives as new Wnt/β-catenin signalling pathway agonists.
Bioorg Chem. 84:285–294. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Si J, Zhou R, Zhao B, Xie Y, Gan L, Zhang
J, Wang Y, Zhou X, Ren X and Zhang H: Effects of ionizing radiation
and HLY78 on the zebrafish embryonic developmental toxicity.
Toxicology. 411:143–153. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mao A, Zhao Q, Zhou X, Sun C, Si J, Zhou
R, Gan L and Zhang H: MicroRNA-449a enhances radiosensitivity by
downregulation of c-Myc in prostate cancer cells. Sci Rep.
6:273462016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ayala-Calvillo E, Mojica-Vazquez LH,
Garcia-Carranca A and Gonzalez-Maya L: Wnt/β-catenin pathway
activation and silencing of the APC gene in HPVpositive human
cervical cancerderived cells. Mol Med Rep. 17:200–208.
2018.PubMed/NCBI
|
|
37
|
Venkatadri R, Iyer AKV, Kaushik V and Azad
N: A novel resveratrol-salinomycin combination sensitizes
ER-positive breast cancer cells to apoptosis. Pharmacol Rep.
69:788–797. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Guo X, Zhang L, Fan Y, Zhang D, Qin L,
Dong S and Li G: Oxysterol-binding protein-related protein 8
inhibits gastric cancer growth through induction of er stress,
inhibition of Wnt signaling, and activation of apoptosis. Oncol
Res. 25:799–808. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang J and Gao Y: CCAT-1 promotes
proliferation and inhibits apoptosis of cervical cancer cells via
the Wnt signaling pathway. Oncotarget. 8:68059–68070. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang Y, Liu B, Zhao Q, Hou T and Huang X:
Nuclear localizaiton of beta-catenin is associated with poor
survival and chemo-/radioresistance in human cervical squamous cell
cancer. Int J Clin Exp Pathol. 7:3908–3917. 2014.PubMed/NCBI
|
|
41
|
Hai B, Yang Z, Shangguan L, Zhao Y, Boyer
A and Liu F: Concurrent transient activation of Wnt/β-catenin
pathway prevents radiation damage to salivary glands. Int J Radiat
Oncol Biol Phys. 83:e109–116. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Saha S, Aranda E, Hayakawa Y, Bhanja P,
Atay S, Brodin NP, Li J, Asfaha S, Liu L, Tailor Y, et al:
Macrophage-derived extracellular vesicle-packaged WNTs rescue
intestinal stem cells and enhance survival after radiation injury.
Nat Commun. 7:130962016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang S, Yin J, Chen D, Nie F, Song X, Fei
C, Miao H, Jing C, Ma W, Wang L, et al: Small-molecule modulation
of Wnt signaling via modulating the Axin-LRP5/6 interaction. Nat
Chem Biol. 9:579–585. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xiao CH, Yu HZ, Guo CY, Wu ZM, Cao HY, Li
WB and Yuan JF: Long non-coding RNA TUG1 promotes the proliferation
of colorectal cancer cells through regulating Wnt/β-catenin
pathway. Oncol Lett. 16:5317–5324. 2018.PubMed/NCBI
|
|
45
|
Pereira-Suárez AL, Meraz MA, Lizano M,
Estrada-Chávez C, Hernández F, Olivera P, Pérez E, Padilla P, Yaniv
M, Thierry F and García-Carrancá A: Frequent alterations of the
β-catenin protein in cancer of the uterine cervix. Tumour Biol.
23:45–53. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sunada S, Hirakawa H, Fujimori A, Uesaka M
and Okayasu R: Oxygen enhancement ratio in radiation-induced
initial dsbs by an optimized flow cytometry-based Γ-H2AX analysis
in A549 human cancer cells. Radiat Res. 188:591–594. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Takahashi A, Yamakawa N, Kirita T, Omori
K, Ishioka N, Furusawa Y, Mori E, Ohnishi K and Ohnishi T: DNA
damage recognition proteins localize along heavy ion induced tracks
in the cell nucleus. J Radiat Res. 49:645–652. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yan J, Xie Y, Zhang Q, Gan L, Wang F, Li
H, Si J and Zhang H: Dynamic recognition and repair of DNA complex
damage. J Cell Physiol. 234:13014–13020. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu X, Li P, Hirayama R, Niu Y, Liu X,
Chen W, Jin X, Zhang P, Ye F, Zhao T, et al: Genistein sensitizes
glioblastoma cells to carbon ions via inhibiting DNA-PKcs
phosphorylation and subsequently repressing NHEJ and delaying HR
repair pathways. Radiother Oncol. 129:84–94. 2018. View Article : Google Scholar : PubMed/NCBI
|
